Isao Fukasawa
Overview
    Explore the profile of Isao Fukasawa including associated specialties, affiliations and a list of published articles.
           
  Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
  
  
  Snapshot
          Snapshot
              Articles
              3
            
            
              Citations
              53
            
            
              Followers
              0
            
  
  Related Specialties
          Related Specialties
  Top 10 Co-Authors
          Top 10 Co-Authors
  Published In
          Published In
  Affiliations
        Affiliations
    Soon will be listed here.
  
  Recent Articles
          1.
        
    
    Murayama H, Kanemaru K, Yoshioka H, Fukamachi A, Shimizu T, Omata T, et al.
  
  
    Neurol Med Chir (Tokyo)
    . 2023 Aug;
          63(10):464-472.
    
    PMID: 37612120
  
  
          Aneurysmal subarachnoid hemorrhage (SAH) treatment has progressed, and patients are rapidly aging in Japan. Consequently, dynamic changes must have emerged in the clinical practice of SAH. This study aimed to...
      
2.
        
    
    Senbokuya N, Kinouchi H, Kanemaru K, Ohashi Y, Fukamachi A, Yagi S, et al.
  
  
    J Neurosurg
    . 2012 Oct;
          118(1):121-30.
    
    PMID: 23039152
  
  
          Object: Cerebral vasospasm following aneurysmal subarachnoid hemorrhage (SAH) is a major cause of subsequent morbidity and mortality. Cilostazol, a selective inhibitor of phosphodiesterase 3, may attenuate cerebral vasospasm because of...
      
3.
        
    Platelet aggregometry in the presence of PGE(1) provides a reliable method for cilostazol monitoring
  
  
    
    Satoh K, Fukasawa I, Kanemaru K, Yoda S, Kimura Y, Inoue O, et al.
  
  
    Thromb Res
    . 2012 Jun;
          130(4):616-21.
    
    PMID: 22728022
  
  
          Introduction: Cilostazol has been shown to be effective for prevention and treatment of cerebral infarction. However, there appears to be no widely accepted method appropriate for monitoring cilostazol. We attempted...